Pinned
Here is a running thread of the articles we have published in 2023 with links to tweetorials when possible
But first a summary of the last 2 years, and links to all papers
vkprasadlab.com/publications
VKPrasadLab
676 posts
VKPrasadLab
@vkprasadlab
These posts were issued before my FDA employment and do not necessarily represent the views of the FDA or the United States. The account is now inactive.
Joined April 2021
- Pausing NIH study sections is not a big deal NIH desperately needs reform
00:00 - Here are the peer reviewed papers we worked on in 2021 👇👇 Lots of terrific collaborations with smart people
- Now out in Dig Health; We analyze Facebook's fact checking. During the pandemic, they relied heavily on high volume twitter users. In one case, user had already tweeted negatively about a paper before being selected to 'fact check' it. Seems problematic journals.sagepub.com/doi/pdf/10.117…
- Red dye #3, RCTs for boosters, and what would actually give American's health
00:00 - The following is a list of all the articles we have published in 2021 1. This paper provides an overview of the indications, mechanism of action, and side effects of targeted cancer therapies.
- The following is a list of all the articles we have published in 2022 1.Our first @vkprasadlab article of 2022 Led by UCLA Chief Jack Sharp, we show 57% of time FDA allows studies that DO NOT USE USA staging This means there may be errors in staging or occult disease that needs treatment Which may bias results 2 win 🧵 rdcu.be/cE8nL
- At long last; This project took years to complete, and required a dream team of authors, but, at last, here you have it.... Reversals in hematology oncology over the last decade Open access! Credit to Alyson Haslam, the mastermind of this👇 rdcu.be/crQpQ
- Just out in the British Journal of Haemaotology Ida-cel costs 420,000 per dose and cures no one Is this sustainable? reasonable? prudent? drug development By Logan Powell, @dgermain21 and @VPrasadMDMPH Free link: onlinelibrary.wiley.com/doi/epdf/10.11…
- Just OUT ahead-of-print, John Ioannidis & I discuss Constructive and Obsessive Critics in Science I think we all see the latter on Twitter They focus on individuals & not ideas 👇👇 Often Lack technical expertise & make scientific debates -> moral ones 🧵 onlinelibrary.wiley.com/doi/abs/10.111…
- This week in @JAMAInternalMed we explore the relationship between drug price and anti-cancer drug benefit (2015-20), led by @miljko & jordan tuia @vkprasadlab We have been working in this space for 10 years now First, some background 🧵🧵 jamanetwork.com/journals/jamai…
- Medical Student and VKPrasadLab member, Logan Powell, is participating in an IRONMAN triathlon to raise money for charity – donations can be made at the link below! ironmanfoundation.donordrive.com/index.cfm?fuse…
- Our new paper OUT TODAY We calculate the cost to avert a SINGLE DFS event of all the new "game-changer" Cancer drugs Median is 1.6 MILLION USD, up to 2.6 MIL!! These costs will BANKRUPT us Based on power calcs, this is the trial GOAL! No surprise Sad! jamanetwork.com/journals/jaman…
